School of Medicine Homepage
Emory University Shield
  • About
    • Our Vision
    • Academic Departments
    • Our Leadership
    • Health Care Partnerships
    • Diversity, Equity, & Inclusion
    • Location
    • Supporting Our People
    • Our Faculty
    • History
    • News
    • Events
    • Contact Us
  • Education
    • Degree and Certificate Programs
    • Academic Departments
    • Residents & Fellows
    • Postdoctoral Training
    • Continuing Medical Education
    • Admissions
    • Cost and Financial Aid
    • Student Resources
  • Research
    • Research Innovation
    • Conducting Research
    • Core Facilities
    • Research Centers
    • Research Training
    • Academic Departments
    • Find a Researcher
    • Research News
  • Clinical Experience
    • Where We Work
    • Caring for a Diverse Population
    • Faculty Clinical Experience
    • Advanced Patient Care
    • Academic Departments
    • Community Learning
  • Giving
  • Directory

Directory section navigation

  • Faculty Profiles

Emory University School of Medicine

  • About
    • Sub link
      Our Vision
    • Sub link
      Academic Departments
    • Sub link
      Our Leadership
    • Sub link
      Health Care Partnerships
    • Sub link
      Diversity, Equity, & Inclusion
    • Sub link
      Location
    • Sub link
      Supporting Our People
    • Sub link
      Our Faculty
    • Sub link
      History
    • Sub link
      News
    • Sub link
      Events
    • Sub link
      Contact Us
  • Education
    • Sub link
      Degree and Certificate Programs
    • Sub link
      Academic Departments
    • Sub link
      Residents & Fellows
    • Sub link
      Postdoctoral Training
    • Sub link
      Continuing Medical Education
    • Sub link
      Admissions
    • Sub link
      Cost and Financial Aid
    • Sub link
      Student Resources
  • Research
    • Sub link
      Research Innovation
    • Sub link
      Conducting Research
    • Sub link
      Core Facilities
    • Sub link
      Research Centers
    • Sub link
      Research Training
    • Sub link
      Academic Departments
    • Sub link
      Find a Researcher
    • Sub link
      Research News
  • Clinical Experience
    • Sub link
      Where We Work
    • Sub link
      Caring for a Diverse Population
    • Sub link
      Faculty Clinical Experience
    • Sub link
      Advanced Patient Care
    • Sub link
      Academic Departments
    • Sub link
      Community Learning
  • Giving
  • Directory
  • Home School of Medicine Home
  • Directory

Profile

Olatunji Alese MD

  • Department of Hematology and Medical Oncology
    Associate Professor
  • (404) 778-6639
  • olatunji.alese@emory.edu
Head shot of Olatunji Alese

Overview

A board certified medical oncologist, Dr. Alese specializes in the treatment of gastrointestinal cancers, particularly colorectal cancer. He joined the clinical staff at Winship Cancer Institute as a practicing physician in July 2015.

Dr. Alese serves as director of gastrointestinal oncology at Winship Cancer Institute of Emory University.

Dr. Alese is a member of the Discovery and Developmental Therapeutics research program at Winship Cancer Institute. He previously served on the Advisory Group of ASCO International Affairs Committee, and he is a member of several professional organizations.

Dr. Alese received his MD from University of Ibadan, Nigeria in 2000. His postgraduate medical education included residency training at University College Hospital in Nigeria and New York Medical College - Metropolitan Hospital Center. He completed his fellowship in hematology/oncology at Winship Cancer Institute of Emory University.

Dr. Alese's research focuses on colorectal cancer and health disparities.

Dr. Alese has several awards including the American Society of Clinical Oncology (ASCO) International Development and Education Award (IDEA), and ECOG Foundation/Paul Carbone, MD Fellowship award. A previous German Academic Exchange Service (DAAD) scholar, his additional distinctions and awards include University of Ibadan Skilled Hands Award, UICC International Cancer Technology Transfer Fellowship, European Society for Medical Oncology (ESMO) TRU Visit Grant, and 2014 ASCO Merit award.

Academic Appointment

  • Associate Professor, Department of Hematology and Medical Oncology, Emory University School of Medicine

Education

Degrees

  • MD from University of Ibadan, Ibadan

Research

Publications

  • Utilizing Patient Input in Rectal Cancer Trial Design.
    J Natl Cancer Inst
    03/19/2025 Authors: Alvarez J; Zambare W; George M; Garcia R; Gallagher P; Kitchens C; Bercz A; Kim MJ; Romesser PB; Cercek A
  • Mechanism of enhancing chemotherapy efficacy in pancreatic ductal adenocarcinoma with paricalcitol and hydroxychloroquine.
    Cell Rep Med Volume: 6 Page(s): 101881
    01/21/2025 Authors: Nagaraju GP; Saddala MS; Foote JB; Khaliq AM; Masood A; Golivi Y; Bandi DSR; Sarvesh S; Reddy SP; Switchenko J
  • Perceptions and Needs for a Technology-Based Dyadic Intervention on Symptom Management Among Patients With Colorectal Cancer and Their Caregivers: A Qualitative Study.
    Cancer Nurs
    11/29/2024 Authors: Epari A; Kim K; Xiao C; Porter LS; Alese OB; Northouse L; Liu D; Graetz I; Lin Y
  • Relacorilant plus nab-paclitaxel for the treatment of metastatic pancreatic ductal adenocarcinoma: results from the open-label RELIANT study.
    Oncologist Volume: 29 Page(s): 957 - 965
    11/04/2024 Authors: Borazanci EH; Bahary N; Chung V; Huyck TK; Kio EA; Chiorean EG; Skeel RT; Alese OB; Cardin DB; Fountzilas C
  • A pilot study of the immune microenvironment of GI neuroendocrine carcinoma.
    Endocr Relat Cancer Volume: 31
    10/01/2024 Authors: McDonald A; Avadhani V; Oprea-Ilies G; Zakka K; Lesinski GB; Gbolahan OB; Alese O
  • Pertuzumab Plus Trastuzumab in Patients With Biliary Tract Cancer With ERBB2/3 Alterations: Results From the Targeted Agent and Profiling Utilization Registry Study.
    J Clin Oncol Volume: 42 Page(s): 3228 - 3237
    09/20/2024 Authors: Cannon TL; Rothe M; Mangat PK; Garrett-Mayer E; Chiu VK; Hwang J; Vijayvergia N; Alese OB; Dib EG; Duvivier HL
  • Alliance A022104/NRG-GI010: The Janus Rectal Cancer Trial: a randomized phase II/III trial testing the efficacy of triplet versus doublet chemotherapy regarding clinical complete response and disease-free survival in patients with locally advanced rectal cancer.
    BMC Cancer Volume: 24 Page(s): 901
    07/26/2024 Authors: Alvarez JA; Shi Q; Dasari A; Garcia-Aguilar J; Sanoff H; George TJ; Hong T; Yothers G; Philip P; Nelson G
  • Development of a Technology-Based Dyadic Intervention for Underserved Colorectal Cancer Patients and Caregivers.
    Stud Health Technol Inform Volume: 315 Page(s): 721 - 722
    07/24/2024 Authors: Lin Y; Xiao C; Porter LS; Alese OB; Higgins MK; Liu DS; Bold D; Hu X
  • Transposon DNA sequences facilitate the tissue-specific gene transfer of circulating tumor DNA between human cells.
    Nucleic Acids Res Volume: 52 Page(s): 7539 - 7555
    07/22/2024 Authors: Cinar M; Martinez-Medina L; Puvvula PK; Arakelyan A; Vardarajan BN; Anthony N; Nagaraju GP; Park D; Feng L; Sheff F
  • ALLIANCE A022104/NRG-GI010: The Janus Rectal Cancer Trial: a randomized phase II/III trial testing the efficacy of triplet versus doublet chemotherapy regarding clinical complete response and disease-free survival in patients with locally advanced rectal cancer.
    medRxiv
    04/27/2024 Authors: Alvarez J; Shi Q; Dasari A; Garcia-Aguilar J; Sanoff H; George TJ; Hong TS; Yothers G; Philip PA; Nelson GD
  • Survival trends for left and right sided colon cancer using population-based SEER database: A forty-five-year analysis from 1975 to 2019.
    Cancer Med Volume: 13 Page(s): e7145
    04/01/2024 Authors: Ulanja MB; Asafo-Agyei KO; Neelam V; Beutler BD; Antwi-Amoabeng D; Governor SB; Rahman GA; Djankpa FT; Ulanja RN; Nteim GB
  • Adjuvant Chemotherapy and Outcomes in Older Adult Patients With Biliary Tract Cancer.
    JAMA Netw Open Volume: 7 Page(s): e2351502
    01/02/2024 Authors: Gbolahan OB; Zhi X; Liu Y; Shah MM; Kooby DA; Alese OB
  • Isolated pulmonary metastases in pancreatic ductal adenocarcinoma: a review of current evidence.
    Cancer Biol Ther Volume: 24 Page(s): 2198479
    12/31/2023 Authors: Adekolujo OS; Wahab A; Akanbi MO; Oyasiji T; Hrinczenko B; Alese OB
  • Shifting Sociodemographic Characteristics of a Phase I Clinical Trial Population at an NCI-Designated Comprehensive Cancer Center in the Southeast.
    Oncologist Volume: 28 Page(s): 1055 - 1063
    12/11/2023 Authors: Lalonde CS; Switchenko JM; Behera M; Bilen MA; Owonikoko TK; Kaufman JL; Nooka AK; Lewis CM; Hitron E; Collins H
  • Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002): a randomised, double-blind, phase 3 trial.
    Lancet Oncol Volume: 24 Page(s): 1399 - 1410
    12/01/2023 Authors: Llovet JM; Kudo M; Merle P; Meyer T; Qin S; Ikeda M; Xu R; Edeline J; Ryoo B-Y; Ren Z
  • Phase II trial of nivolumab and metformin in patients with treatment-refractory microsatellite stable metastatic colorectal cancer.
    J Immunother Cancer Volume: 11
    10/01/2023 Authors: Akce M; Farran B; Switchenko JM; Rupji M; Kang S; Khalil L; Ruggieri-Joyce A; Olson B; Shaib WL; Wu C
  • Nivolumab Plus Ipilimumab in Patients With Solid Tumors With ATM Mutations: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study.
    JCO Precis Oncol Volume: 7 Page(s): e2300279
    09/01/2023 Authors: Rohatgi N; Rothe M; Mangat PK; Garrett-Mayer E; Meric-Bernstam F; Pisick E; Alese OB; Reynolds CM; Thota R; Vaccaro GM
  • The impact of COVID-19 on mortality, length of stay, and cost of care among patients with gastrointestinal malignancies: A propensity score-matched analysis.
    Cancer Med Volume: 12 Page(s): 17365 - 17376
    08/01/2023 Authors: Ulanja MB; Beutler BD; Asafo-Agyei KO; Governor SB; Edusa S; Antwi-Amoabeng D; Ulanja RN; Nteim GB; Amankwah M; Neelam V
  • Changes in Prescribing Patterns in Stage III Colon Cancer.
    J Natl Compr Canc Netw Volume: 21 Page(s): 841 - 850.e4
    08/01/2023 Authors: Ou F-S; Walden DJ; Larson JJ; Kang S; Griswold CR; Ueberroth BE; Patel B; Draper A; Raman P; Alese OB
  • A Web-Based Dyadic Intervention to Manage Psychoneurological Symptoms for Patients With Colorectal Cancer and Their Caregivers: Protocol for a Mixed Methods Study.
    JMIR Res Protoc Volume: 12 Page(s): e48499
    06/28/2023 Authors: Lin Y; Porter LS; Chee W; Alese OB; Curseen KA; Higgins MK; Northouse L; Xiao C
  • Update on Emerging Therapies for Advanced Colorectal Cancer.
    Am Soc Clin Oncol Educ Book Volume: 43 Page(s): e389574
    05/01/2023 Authors: Alese OB; Wu C; Chapin WJ; Ulanja MB; Zheng-Lin B; Amankwah M; Eads J
  • Survival and Prognostic Factors in Patients With Pancreatic Colloid Carcinoma Compared With Pancreatic Ductal Adenocarcinoma.
    Pancreas Volume: 52 Page(s): e75 - e84
    01/01/2023 Authors: Khalil L; Huang Z; Zakka K; Jiang R; Penley M; Alese OB; Shaib WL; Wu C; Behera M; Reid MD
  • Factors Affecting Clinical Outcomes Among Patients Infected With HIV and Anal Cancer Treated With Modern Definitive Chemotherapy and Radiation Therapy.
    Adv Radiat Oncol Volume: 8 Page(s): 101155
    01/01/2023 Authors: Pfister NT; Cao Y; Schlafstein AJ; Switchenko J; Patel PR; McDonald MW; Tian S; Landry JC; Alese OB; Gunthel C
  • The Impact of Poorly Differentiated Histology on Immunotherapy in Advanced Gastrointestinal Cancers.
    Oncology Volume: 101 Page(s): 213 - 223
    01/01/2023 Authors: Draper A; Jung EH; Cao Y; Atallah RP; Switchenko J; Kane S; Guadagno J; Jones AT; Brutcher E; Alese OB
  • Race, age, and sex differences on the influence of obesity on colorectal cancer sidedness and mortality: A national cross-sectional study.
    J Surg Oncol Volume: 127 Page(s): 109 - 118
    01/01/2023 Authors: Ulanja MB; Ntafam C; Beutler BD; Antwi-Amoabeng D; Rahman GA; Ulanja RN; Mabrouk T; Governor SB; Djankpa FT; Alese OB
  • ASO Visual Abstract: Prognostic Factors and Survival in Gastrointestinal Extrapulmonary Small Cell Carcinoma-A Retrospective Cohort Study.
    Ann Surg Oncol Volume: 29 Page(s): 8263 - 8264
    12/01/2022 Authors: Ulanja MB; Beutler BD; Antwi-Amoabeng D; Governor SB; Rahman GA; Djankpa FT; Alese OB
  • ASO Author Reflections: Prognostic Factors in Gastrointestinal Extrapulmonary Small Cell Carcinoma Using Real-World Data.
    Ann Surg Oncol Volume: 29 Page(s): 8261 - 8262
    12/01/2022 Authors: Ulanja MB; Beutler BD; Antwi-Amoabeng D; Governor SB; Rahman GA; Djankpa FT; Alese OB
  • Prognostic Factors and Survival in Gastrointestinal Extrapulmonary Small Cell Carcinoma: A Retrospective Cohort Study.
    Ann Surg Oncol Volume: 29 Page(s): 8250 - 8260
    12/01/2022 Authors: Ulanja MB; Beutler BD; Antwi-Amoabeng D; Governor SB; Rahman GA; Djankpa FT; Alese OB
  • Cobimetinib Plus Vemurafenib in Patients With Colorectal Cancer With BRAF Mutations: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study.
    JCO Precis Oncol Volume: 6 Page(s): e2200191
    11/01/2022 Authors: Klute KA; Rothe M; Garrett-Mayer E; Mangat PK; Nazemzadeh R; Yost KJ; Duvivier HL; Ahn ER; Cannon TL; Alese OB
  • Biomarker analysis from a phase II multi-institutional study of nivolumab in patients with advanced refractory biliary tract cancer.
    Eur J Cancer Volume: 176 Page(s): 171 - 180
    11/01/2022 Authors: Kim DW; Kim Y-C; Kovari BP; Chung V; Alese OB; El-Rayes BF; Li D; Park W; Kim RD
  • Role of local therapy in the management of patients with metastatic anal squamous cell carcinoma: a National Cancer Database study.
    J Gastrointest Oncol Volume: 13 Page(s): 2306 - 2321
    10/01/2022 Authors: Atallah RP; Zhang Y; Zakka K; Jiang R; Huang Z; Shaib WL; Diab M; Akce M; Wu C; El-Rayes BF
  • Survival Outcomes of Adjuvant Chemotherapy in Elderly Patients with Stage III Colon Cancer.
    Oncologist Volume: 27 Page(s): 740 - 750
    09/02/2022 Authors: Khalil L; Gao X; Switchenko JM; Alese OB; Akce M; Wu C; Diab M; El-Rayes BF; Shaib WL
  • Cancer healthcare disparities among African Americans in the United States.
    J Natl Med Assoc Volume: 114 Page(s): 236 - 250
    06/01/2022 Authors: Mitchell E; Alese OB; Yates C; Rivers BM; Blackstock W; Newman L; Davis M; Byrd G; Harris AE
  • Circulating Tumor DNA: An Emerging Tool in Gastrointestinal Cancers.
    Am Soc Clin Oncol Educ Book Volume: 42 Page(s): 1 - 20
    04/01/2022 Authors: Alese OB; Cook N; Ortega-Franco A; Ulanja MB; Tan L; Tie J
  • Early-onset pancreatic cancer: a review of molecular mechanisms, management, and survival.
    Oncotarget Volume: 13 Page(s): 828 - 841
    01/01/2022 Authors: Ulanja MB; Moody AE; Beutler BD; Antwi-Amoabeng D; Rahman GA; Alese OB
  • Comparing Somatostatin Analogs in the Treatment of Advanced Gastroenteropancreatic Neuroendocrine Tumors.
    Oncology Volume: 100 Page(s): 131 - 139
    01/01/2022 Authors: Allaw MB; Switchenko JM; Khalil L; Wu C; Alese OB; Akce M; Draper A; Jones AT; El-Rayes B; Shaib W
  • Factors Affecting Inpatient Mortality and Length of Stay in Nonmetastatic Colorectal Cancer: Insights from the National Inpatient Sample.
    Am J Clin Oncol Volume: 45 Page(s): 14 - 21
    01/01/2022 Authors: Ulanja MB; Beutler BD; Antwi-Amoabeng D; Moody AE; Chang PT; Rahman GA; Apanga PA; Alese OB
  • CORRELATIVE ANALYSIS OF BLOOD AND BIOPSY SAMPLES FROM A CLINICAL TRIAL OF HSP90 INHIBITION IN COMBINATION WITH PEMBROLIZUMAB REVEALS INCREASED INTRATUMORAL MYELOID CELL ACCUMULATION AFTER TREATMENT
    Volume: 9 Page(s): A434 - A434
    11/01/2021 Authors: Herting C; Zhang Y; Doxie D; Ware M; Alese O; Wu C; Akce M; Zaidi M; Ruggieri A; Dhodapkar M
  • Role of Resection of the Primary in Metastatic Well-Differentiated Neuroendocrine Tumors.
    Pancreas Volume: 50 Page(s): 1382 - 1391
    11/01/2021 Authors: Shaib WL; Zakka K; Penley M; Jiang R; Akce M; Wu C; Maithel SK; Sarmiento JM; Kooby D; Behera M
  • Correction: A Randomized Trial of Combined PD-L1 and CTLA-4 Inhibition with Targeted Low-dose or Hypofractionated Radiation for Patients with Metastatic Colorectal Cancer.
    Clin Cancer Res Volume: 27 Page(s): 4940
    09/01/2021 Authors: Monjazeb AM; Giobbie-Hurder A; Lako A; Thrash EM; Brennick RC; Kao KZ; Manuszak C; Gentzler RD; Tesfaye A; Jabbour SK
  • A phase I trial of trifluridine/tipiracil in combination with nanoliposomal irinotecan in advanced GI cancers
    Volume: 32 Page(s): S200 - S200
    07/03/2021 Authors: Alese O; Shaib W; Akce M; Diab M; Issa-Boube M; Ekundayo F; Wu C; El-Rayes B
  • Safety and Efficacy of 7 Days on/7 Days off Versus 14 Days on/7 Days off Schedules of Capecitabine in Patients with Metastatic Colorectal Cancer: A Retrospective Review.
    Clin Colorectal Cancer Volume: 20 Page(s): 153 - 160
    06/01/2021 Authors: Bryson E; Sakach E; Patel U; Watson M; Hall K; Draper A; Davis C; Goyal S; Alese O; Akce M
  • A Randomized Trial of Combined PD-L1 and CTLA-4 Inhibition with Targeted Low-Dose or Hypofractionated Radiation for Patients with Metastatic Colorectal Cancer.
    Clin Cancer Res Volume: 27 Page(s): 2470 - 2480
    05/01/2021 Authors: Monjazeb AM; Giobbie-Hurder A; Lako A; Thrash EM; Brennick RC; Kao KZ; Manuszak C; Gentzler RD; Tesfaye A; Jabbour SK
  • Survival Outcomes of Acinar Cell Pancreatic Cancer: A National Cancer Database Analysis.
    Pancreas Volume: 50 Page(s): 529 - 536
    04/01/2021 Authors: Shaib WL; Zakka K; Huang W; Chen Z; Alese OB; Wu C; Akce M; El-Rayes BF
  • Is adjuvant chemotherapy beneficial for stage II-III goblet cell carcinoid/goblet cell adenocarcinoma of the appendix?
    Surg Oncol Volume: 36 Page(s): 120 - 129
    03/01/2021 Authors: Zakka K; Williamson S; Jiang R; Reid MD; Alese OB; Shaib WL; Wu C; Behera M; El-Rayes BF; Akce M
  • Impact of Sarcopenia, BMI, and Inflammatory Biomarkers on Survival in Advanced Hepatocellular Carcinoma Treated With Anti-PD-1 Antibody.
    Am J Clin Oncol Volume: 44 Page(s): 74 - 81
    02/01/2021 Authors: Akce M; Liu Y; Zakka K; Martini DJ; Draper A; Alese OB; Shaib WL; Wu C; Wedd JP; Sellers MT
  • Perioperative therapy in metastatic colorectal cancer: Pattern of use and survival outcomes.
    J Surg Oncol Volume: 123 Page(s): 596 - 605
    02/01/2021 Authors: Alese OB; Zakka K; Huo X; Jiang R; Shaib WL; Akce M; Behera M; Sullivan P; Wu C; El-Rayes BF
  • High-Risk Features Are Prognostic in dMMR/MSI-H Stage II Colon Cancer.
    Front Oncol Volume: 11 Page(s): 755113
    01/01/2021 Authors: Mohamed A; Jiang R; Philip PA; Diab M; Behera M; Wu C; Alese O; Shaib WL; Gaines TM; Balch GG
  • Impact of Tumor Side on Clinical Outcomes in Stage II and III Colon Cancer With Known Microsatellite Instability Status.
    Volume: 11 Page(s): 592351
    01/01/2021 Authors: Akce M; Zakka K; Jiang R; Williamson S; Alese OB; Shaib WL; Wu C; Behera M; El-Rayes BF
  • Predictive and Prognostic Effects of Primary Tumor Size on Colorectal Cancer Survival.
    Front Oncol Volume: 11 Page(s): 728076
    01/01/2021 Authors: Alese OB; Zhou W; Jiang R; Zakka K; Huang Z; Okoli C; Shaib WL; Akce M; Diab M; Wu C
  • Impact of high-risk features for stage II adenocarcinoma of the appendix.
    Volume: 27 Page(s): 100329
    01/01/2021 Authors: Akce M; Zakka K; Penley M; Jiang R; Khalil L; Alese OB; Shaib WL; Wu C; Behera M; El-Rayes BF
  • Clinical Outcomes Among Patients With Metastatic Pancreatic Ductal Adenocarcinoma Treated With Liposomal Irinotecan.
    Front Oncol Volume: 11 Page(s): 678070
    01/01/2021 Authors: Yu KH; Hendifar AE; Alese OB; Draper A; Abdelrahim M; Burns E; Khan G; Cockrum P; Bhak RH; Nguyen C
  • INVESTIGATING THE CLINICAL SAFETY, EFFICACY, AND IMMUNE MODULATION OF COMBINED XL888 AND PEMBROLIZUMAB IN METASTATIC GASTROINTESTINAL MALIGNANCIES
    Volume: 8 Page(s): A202 - A203
    11/01/2020 Authors: Herting C; Zhang Y; Doxie D; Farren M; Ware M; Alese O; Wu C; Shaib W; Akce M; Zaidi M
  • Phase I and Pharmacokinetic Study of Romidepsin in Patients with Cancer and Hepatic Dysfunction: A National Cancer Institute Organ Dysfunction Working Group Study.
    Clin Cancer Res Volume: 26 Page(s): 5329 - 5337
    10/15/2020 Authors: Connolly RM; Laille E; Vaishampayan U; Chung V; Kelly K; Dowlati A; Alese OB; Harvey RD; Haluska P; Siu LL
  • Phase 1 safety and pharmacodynamic study of lenalidomide combined with everolimus in patients with advanced solid malignancies with efficacy signal in adenoid cystic carcinoma.
    Br J Cancer Volume: 123 Page(s): 1228 - 1234
    10/01/2020 Authors: Harvey RD; Carthon BC; Lewis C; Hossain MS; Zhang C; Chen Z; Harris WB; Alese OB; Shaib W; Bilen MA
  • A US multicenter chart review study of patients with metastatic pancreatic ductal adenocarcinoma receiving liposomal irinotecan after gemcitabine-based therapy
    Volume: 29 Page(s): 36 - 37
    10/01/2020 Authors: Yu KH; Hendifar A; Alese O; Draper A; Abdelrahim M; Burns E; Khan G; Cockrum P; Bhak R; DerSarkissian M
  • Survival outcome of adjuvant chemotherapy in deficient mismatch repair stage III colon cancer.
    Cancer Volume: 126 Page(s): 4136 - 4147
    09/15/2020 Authors: Shaib WL; Zakka KM; Jiang R; Yan M; Alese OB; Akce M; Wu C; Behera M; El-Rayes BF
  • Real-world treatment patterns and effectiveness of liposomal irinotecan in a NAPOLI1-based regimen among patients with metastatic pancreatic ductal adenocarcinoma (mPDAC): A multi-academic center chart review
    Volume: 31 Page(s): S950 - S951
    09/01/2020 Authors: Yu KH; Hendifar A; Alese O; Draper A; Abdelrahim M; Burns E; Khan G; Cockrum P; Bhak R; Nguyen C
  • Radiation as a Single-Modality Treatment in Localized Pancreatic Cancer.
    Pancreas Volume: 49 Page(s): 822 - 829
    07/01/2020 Authors: Shaib WL; Zakka K; Shahin AA; Yared F; Switchenko JM; Wu C; Akce M; Alese OB; Patel PR; Mcdonald M
  • A Phase I Study of Safety, Pharmacokinetics, and Pharmacodynamics of Concurrent Everolimus and Buparlisib Treatment in Advanced Solid Tumors.
    Clin Cancer Res Volume: 26 Page(s): 2497 - 2505
    06/01/2020 Authors: Owonikoko TK; Harvey RD; Carthon B; Chen Z; Lewis C; Collins H; Zhang C; Lawson DH; Alese OB; Bilen MA
  • A Phase 2 Multi-institutional Study of Nivolumab for Patients With Advanced Refractory Biliary Tract Cancer.
    JAMA Oncol Volume: 6 Page(s): 888 - 894
    06/01/2020 Authors: Kim RD; Chung V; Alese OB; El-Rayes BF; Li D; Al-Toubah TE; Schell MJ; Zhou J-M; Mahipal A; Kim BH
  • Adjuvant concurrent chemoradiotherapy in extrahepatic cholangiocarcinoma.
    Volume: 38
    05/20/2020 Authors: Shaib WL; Zakka KM; Tian F; Chen Z; Patel PR; Lin JY; Wu C; Akce M; Alese OB; El-Rayes BF
  • A multicenter chart review study of patients with metastatic pancreatic ductal adenocarcinoma receiving liposomal irinotecan after gemcitabine-based therapy.
    Volume: 38
    05/20/2020 Authors: Yu KH; Hendifar AE; Alese OB; Draper A; Abdelrahim M; Burns E; Khan GN; Cockrum P; Bhak R; DerSarkissian M
  • Blood-based next-generation sequencing analysis of neuroendocrine neoplasms.
    Oncotarget Volume: 11 Page(s): 1749 - 1757
    05/12/2020 Authors: Zakka K; Nagy R; Drusbosky L; Akce M; Wu C; Alese OB; El-Rayes BF; Kasi PM; Mody K; Starr J
  • High-Grade Gastrointestinal Neuroendocrine Carcinoma Management and Outcomes: A National Cancer Database Study.
    Oncologist Volume: 25 Page(s): e877
    05/01/2020 Authors: Alese OB; Jiang R; Shaib W; Wu C; Akce M; Behera M; El-Rayes BF
  • Blood-Based Next-Generation Sequencing Analysis of Appendiceal Cancers.
    Oncologist Volume: 25 Page(s): 414 - 421
    05/01/2020 Authors: Shaib WL; Zakka K; Staley C; Roberts A; Akce M; Wu C; Alese OB; El-Rayes BF
  • In-hospital 30-day mortality for older patients with pancreatic cancer undergoing pancreaticoduodenectomy.
    J Geriatr Oncol Volume: 11 Page(s): 660 - 667
    05/01/2020 Authors: Shaib WL; Zakka K; Hoodbhoy FN; Belalcazar A; Kim S; Cardona K; Russell MC; Maithel SK; Sarmiento JM; Wu C
  • Combined Effect of Sarcopenia and Systemic Inflammation on Survival in Patients with Advanced Stage Cancer Treated with Immunotherapy.
    Oncologist Volume: 25 Page(s): e528 - e535
    03/01/2020 Authors: Bilen MA; Martini DJ; Liu Y; Shabto JM; Brown JT; Williams M; Khan AI; Speak A; Lewis C; Collins H
  • Young Adults With Pancreatic Cancer: National Trends in Treatment and Outcomes.
    Pancreas Volume: 49 Page(s): 341 - 354
    03/01/2020 Authors: Alese OB; Jiang R; Shaib W; Wu C; Akce M; Gaines T; Ni L; Behera M; El-Rayes BF
  • Clinical and molecular markers of immune checkpoint inhibitor (ICI) response in dMMR colorectal cancer (CRC) patients (pts)
    Volume: 38
    02/01/2020 Authors: Sahin IH; Goyal S; Pumpalova YS; Sonbol MB; Das S; Haraldsdottir S; Chen Z; Akce M; Alese OB; Shaib WL
  • Is adjuvant chemotherapy beneficial for stage II-III goblet cell tumors of the appendix?
    Volume: 38
    02/01/2020 Authors: Zakka KM; Williamson S; Jiang R; Alese OB; Shaib WL; Wu C; Behera M; El-Rayes BF; Akce M
  • The impact of inflammatory biomarkers, BMI, and sarcopenia on survival in advanced hepatocellular carcinoma treated with immunotherapy
    Volume: 38
    02/01/2020 Authors: Akce M; Liu Y; Zakka KM; Martini DJ; Draper A; Alese OB; Shaib WL; Wu C; Wedd J; Sellers MT
  • Clinicopathological features and survival outcomes of rare histologic variants of gallbladder cancer.
    J Surg Oncol Volume: 121 Page(s): 294 - 302
    02/01/2020 Authors: Akce M; Zakka K; Penley M; Jiang R; Alese OB; Shaib WL; Wu C; Behera M; El-Rayes BF
  • Adiposity may predict survival in patients with advanced stage cancer treated with immunotherapy in phase 1 clinical trials.
    Cancer Volume: 126 Page(s): 575 - 582
    02/01/2020 Authors: Martini DJ; Kline MR; Liu Y; Shabto JM; Williams MA; Khan AI; Lewis C; Collins H; Akce M; Kissick HT
  • How I Treat Advanced Hepatocellular Cancer With Immunotherapy
    Page(s): 295 - 303
    01/01/2020 Authors: Alese OB; Zakka K
  • Correlation Patterns Among B7 Family Ligands and Tryptophan Degrading Enzymes in Hepatocellular Carcinoma.
    Front Oncol Volume: 10 Page(s): 1632
    01/01/2020 Authors: Chinnadurai R; Scandolara R; Alese OB; Arafat D; Ravindranathan D; Farris AB; El-Rayes BF; Gibson G
  • Combined Effect of Sarcopenia and Systemic Inflammation on Survival in Patients with Advanced Stage Cancer Treated with Immunotherapy.
    Oncologist
    12/05/2019 Authors: Bilen MA; Martini DJ; Liu Y; Shabto JM; Brown JT; Williams M; Khan AI; Speak A; Lewis C; Collins H
  • Clinical outcomes of advanced stage cancer patients treated with sequential immunotherapy in phase 1 clinical trials.
    Invest New Drugs Volume: 37 Page(s): 1198 - 1206
    12/01/2019 Authors: Martini DJ; Liu Y; Shabto JM; Lewis C; Kline MR; Collins H; Akce M; Kissick HT; Carthon BC; Shaib WL
  • Analysis of racial disparities in the treatment and outcomes of colorectal cancer in young adults.
    Cancer Epidemiol Volume: 63 Page(s): 101618
    12/01/2019 Authors: Alese OB; Jiang R; Zakka KM; Wu C; Shaib W; Akce M; Behera M; El-Rayes BF
  • Clinical Outcomes of Small Bowel Adenocarcinoma.
    Volume: 18 Page(s): 257 - 268
    12/01/2019 Authors: Akce M; Jiang R; Zakka K; Wu C; Alese OB; Shaib WL; Behera M; El-Rayes BF
  • Optimizing cancer care for hepatocellular carcinoma at a safety-net hospital: The value of a multidisciplinary disease management team.
    J Surg Oncol Volume: 120 Page(s): 1365 - 1370
    12/01/2019 Authors: Duininck G; Lopez-Aguiar AG; Lee RM; Miller L; Dariushnia S; Wu C; Alese OB; Lin JY; Wedd J; Adams A
  • Rosai-Dorfman Disease of the Pancreas Shows Significant Histologic Overlap With IgG4-related Disease.
    Am J Surg Pathol Volume: 43 Page(s): 1536 - 1546
    11/01/2019 Authors: Tracht J; Reid MD; Xue Y; Madrigal E; Sarmiento JM; Kooby D; Alese OB; Krasinskas AM
  • Immune checkpoint inhibitors for the treatment of MSI-H/MMR-D colorectal cancer and a perspective on resistance mechanisms.
    Br J Cancer Volume: 121 Page(s): 809 - 818
    11/01/2019 Authors: Sahin IH; Akce M; Alese O; Shaib W; Lesinski GB; El-Rayes B; Wu C
  • The Effect of Neoadjuvant Radiotherapy on Tumor Regression Grade in Resected Pancreatic Adenocarcinoma
    Volume: 105 Page(s): E241 - E242
    09/01/2019 Authors: Patel PR; Jiang C; Xu KM; Tanenbaum DG; Rupji M; Krasinskas A; El-rayes B; Shaib W; Alese O; Sarmiento J
  • Sites of metastasis and association with clinical outcome in advanced stage cancer patients treated with immunotherapy.
    BMC Cancer Volume: 19 Page(s): 857
    08/29/2019 Authors: Bilen MA; Shabto JM; Martini DJ; Liu Y; Lewis C; Collins H; Akce M; Kissick H; Carthon BC; Shaib WL
  • Induction Therapy in Localized Pancreatic Cancer.
    Pancreas Volume: 48 Page(s): 913 - 919
    08/01/2019 Authors: Shaib WL; Sayegh L; Zhang C; Belalcazar A; Ip A; Alese OB; Akce M; Wu C; Qu Y; Maithel SK
  • Comparison of neoadjuvant FOLFIRINOX alone vs FOLFIRINOX plus stereotactic body radiation as immune-modulators of the pancreatic adenocarcinoma microenvironment
    Volume: 79
    07/01/2019 Authors: Farren MR; Shaib W; Zaidi M; Sayegh L; Kooby D; Maithel S; Krasinskas A; Alese O; Sarmiento J; El-Rayes B
  • Heat shock protein 90 inhibitors alter pancreatic stellate cell cytokine production and enhances the efficacy of immune checkpoint blockade in pancreatic cancer
    Volume: 79
    07/01/2019 Authors: Zaidi M; Zhang Y; Ware MB; Farren MR; Komar H; Olson B; Nagaraju GP; Akce M; Alese O; Maithel S
  • High-Grade Gastrointestinal Neuroendocrine Carcinoma Management and Outcomes: A National Cancer Database Study.
    Oncologist Volume: 24 Page(s): 911 - 920
    07/01/2019 Authors: Alese OB; Jiang R; Shaib W; Wu C; Akce M; Behera M; El-Rayes BF
  • Blood-based next-generation sequencing analysis of neuroendocrine tumors.
    Volume: 37
    05/20/2019 Authors: Shaib WL; Roberts A; Zakka KM; Akce M; Wu C; Alese OB; El-Rayes BF; Kasi PM; Starr JS
  • Perioperative therapy in patients with metastatic colorectal cancer.
    Volume: 37
    05/20/2019 Authors: Alese OB; Zakka KM; Huo X; Jiang R; Shaib WL; Wu C; Akce M; Sullivan PS; Behera M; El-Rayes BF
  • US Cancer Centers of Excellence Strategies for Increased Inclusion of Racial and Ethnic Minorities in Clinical Trials.
    J Oncol Pract Volume: 15 Page(s): e289 - e299
    04/01/2019 Authors: Regnante JM; Richie NA; Fashoyin-Aje L; Vichnin M; Ford M; Roy UB; Turner K; Hall LL; Gonzalez E; Esnaola N
  • Clinical outcomes of hepatocellular carcinoma variants compared to hepatocellular carcinoma.
    Volume: 37
    02/01/2019 Authors: Zakka KM; Jiang R; Alese OB; Shaib WL; Wu C; Wedd J; Sellers MT; Behera M; El-Rayes BF; Akce M
  • Genomic alterations in appendiceal carcinoma using circulating DNA.
    Volume: 37
    02/01/2019 Authors: Shaib WL; Roberts A; Akce M; Wu C; Alese OB; El-Rayes BF
  • Impact of genomic alterations (GAs) on outcomes and their distribution by age groups in metastatic colorectal cancer (mCRC) patients (pts)
    Volume: 37
    02/01/2019 Authors: Sahin IH; Chen WH; Chen Z; Akce M; Alese OB; Shaib WL; El-Rayes BF; Wu C
  • Sequential immunotherapy and association with clinical outcomes in advanced-stage cancer patients
    Volume: 7
    02/01/2019 Authors: Bilen M; Martini D; Liu Y; Lewis C; Collins H; Shabto J; Akce M; Kissick H; Carthon B; Shaib W
  • Gastric squamous cell carcinoma and gastric adenosquamous carcinoma, clinical features and outcomes of rare clinical entities: a National Cancer Database (NCDB) analysis.
    J Gastrointest Oncol Volume: 10 Page(s): 85 - 94
    02/01/2019 Authors: Akce M; Jiang R; Alese OB; Shaib WL; Wu C; Behera M; El-Rayes BF
  • Clinical outcomes of rare hepatocellular carcinoma variants compared to pure hepatocellular carcinoma.
    J Hepatocell Carcinoma Volume: 6 Page(s): 119 - 129
    01/01/2019 Authors: Zakka K; Jiang R; Alese OB; Shaib WL; Wu C; Wedd JP; Sellers MT; Behera M; El-Rayes BF; Akce M
  • Role of adjuvant therapy in resected stage IA subcentimeter (T1a/T1b) pancreatic cancer.
    Cancer Volume: 125 Page(s): 57 - 67
    01/01/2019 Authors: Shaib WL; Narayan AS; Switchenko JM; Kane SR; Wu C; Akce M; Alese OB; Patel PR; Maithel SK; Sarmiento JM
  • The prognostic and predictive impact of inflammatory biomarkers in patients who have advanced-stage cancer treated with immunotherapy.
    Cancer Volume: 125 Page(s): 127 - 134
    01/01/2019 Authors: Bilen MA; Martini DJ; Liu Y; Lewis C; Collins HH; Shabto JM; Akce M; Kissick HT; Carthon BC; Shaib WL
  • Sarcopenia and inflammation predicts survival in advanced stage cancer patients (pts) treated with immunotherapy (IO).
    Volume: 29 Suppl 8 Page(s): viii42
    10/01/2018 Authors: Bilen MA; Martini DJ; Shabto JM; Liu Y; Khan AI; Williams MA; Lewis C; Collins HH; Kissick H; Carthon BC
  • Sites of metastasis and association with clinical outcome (CO) in advanced stage cancer patients (pts) treated with immunotherapy (IO).
    Ann Oncol Volume: 29 Suppl 8 Page(s): viii433
    10/01/2018 Authors: Bilen MA; Shabto JM; Martini DJ; Liu Y; Lewis C; Collins HH; Akce M; Kissick H; Carthon BC; Shaib WL
  • Analysis of Opioid Use Following Curative Cancer Treatment at a Large Urban Safety-net Hospital.
    Clin J Pain Volume: 34 Page(s): 885 - 889
    10/01/2018 Authors: Cass AS; Alese JT; Kim C; Curry MA; LaFollette JA; Chen Z; Alese OB
  • Blood based biomarkers and association with clinical outcome (CO) in advanced stage patients (pts) treated with immunotherapy (IO)
    Volume: 78
    07/01/2018 Authors: Martini DJ; Liu Y; Lewis C; Collins H; Akce M; Kissick H; Carthon BC; Shaib WL; Alese OB; Pillai R
  • Evaluation of Treatment Patterns and Survival Outcomes in Elderly Pancreatic Cancer Patients: A Surveillance, Epidemiology, and End Results-Medicare Analysis.
    Oncologist Volume: 23 Page(s): 704 - 711
    06/01/2018 Authors: Shaib WL; Jones JS; Goodman M; Sarmiento JM; Maithel SK; Cardona K; Kane S; Wu C; Alese OB; El-Rayes BF
  • A Phase II multi institutional study of nivolumab in patients with advanced refractory biliary tract cancers (BTC).
    Volume: 29 Suppl 5 Page(s): v103
    06/01/2018 Authors: Kim R; Kim D; Alese O; Li D; El-Rayes B; Shah N; Schell M; Zhou J; Chung V
  • Adjuvant treatment for resected sub-centimeter T1 pancreatic cancer.
    Volume: 36
    05/20/2018 Authors: Shaib WL; Naranyan AS; Switchenko JM; Akce M; Sarmiento J; Maithel S; Kooby DA; Patel PR; Cardona K; Alese OB
  • Early change in blood-based biomarkers and association with clinical outcome (CO) in advanced stage cancer patients (pts) treated with immunotherapy (IO)
    Volume: 36
    05/20/2018 Authors: Martini DJ; Liu Y; Lewis CM; Shabto JM; Akce M; Kissick H; Carthon BC; Shaib WL; Alese OB; Pillai RN
  • A phase I/II study of trifluridine/tipiracil (TAS-102) in combination with nanoliposomal irinotecan (NAL-IRI) in advanced GI cancers.
    Volume: 36
    05/20/2018 Authors: Alese OB; Shaib WL; Akce M; Wu C; El-Rayes BF
  • Incidence, treatment and survival outcomes of small bowel adenocarcinomas: A National Cancer Database (NCDB) analysis.
    Volume: 36
    05/20/2018 Authors: Akce M; Jiang R; Wu C; Alese OB; Shaib WL; Behera M; El-Rayes BF
  • Retrospective study of the safety of administering pegfilgrastim on the same day of 5-Fluorouracil pump disconnect.
    Volume: 36
    05/20/2018 Authors: Patel N; Wu C; Draper A; LaFollette JA; Brutcher E; El-Rayes BF; Alese OB; Shaib WL; Akce M; Chen Z
  • Altering the cytokine profile in the pancreatic cancer microenvironment with heat shock protein-90 inhibitors to enhance immunotherapy.
    Volume: 200
    05/01/2018 Authors: Lesinski GB; Zhang Y; Farren MR; Komar H; Ware B; Olson B; Zaidi M; Nagaraju GP; Akce M; Alese OB
  • Phase 1b study of pasireotide, everolimus, and selective internal radioembolization therapy for unresectable neuroendocrine tumors with hepatic metastases.
    Cancer Volume: 124 Page(s): 1992 - 2000
    05/01/2018 Authors: Kim HS; Shaib WL; Zhang C; Nagaraju GP; Wu C; Alese OB; Chen Z; Brutcher E; Renfroe M; El-Rayes BF
  • Resection of pancreatic cancer following induction chemotherapy.
    Volume: 36
    02/01/2018 Authors: Shaib WL; Sayegh L; Alese O; Maithel S; Cardona K; Sarmiento J; Belalcazar A; Ip A; Qu Y; Akce M
  • Epidemiology and treatment of high-grade gastrointestinal neuroendocrine tumors (HG-GI-NETs)
    Volume: 36
    02/01/2018 Authors: Alese OB; Jiang R; Shaib WL; Wu CS-Y; Akce M; Behera M; El-Rayes BF
  • Phase Ib trial of pembrolizumab and XL888 in patients with advanced gastrointestinal malignancies.
    Volume: 36
    02/01/2018 Authors: Akce M; Alese OB; Shaib WL; Wu CS-Y; Lesinski GB; El-Rayes BF
  • Race-, Age-, and Gender-Based Characteristics and Toxicities of Targeted Therapies on Phase I Trials.
    Oncology Volume: 95 Page(s): 138 - 146
    01/01/2018 Authors: Owonikoko TK; Busari AK; Kim S; Chen Z; Akintayo A; Lewis C; Carthon BC; Alese OB; El-Rayes BF; Ramalingam SS
  • Appendiceal Mucinous Neoplasms: Diagnosis and Management.
    Oncologist Volume: 23 Page(s): 137
    01/01/2018 Authors: Shaib WL; Assi R; Shamseddine A; Alese OB; Staley C; Memis B; Adsay V; Bekaii-Saab T; El-Rayes BF
  • Appendiceal Mucinous Neoplasms: Diagnosis and Management.
    Oncologist Volume: 22 Page(s): 1107 - 1116
    09/01/2017 Authors: Shaib WL; Assi R; Shamseddine A; Alese OB; Staley C; Memis B; Adsay V; Bekaii-Saab T; El-Rayes BF
  • Racial disparities in treatment and outcomes of colorectal cancer in young adults.
    Volume: 35
    05/20/2017 Authors: Alese OB; Jiang R; Shaib WL; Wu CS-Y; Behera M; El-Rayes BF
  • Treatment, outcomes, and impact of racial disparities on young adults with pancreatic cancer.
    Volume: 35
    05/20/2017 Authors: Alese OB; Jiang R; Shaib WL; Wu CS-Y; Behera M; El-Rayes BF
  • Rosai-Dorfman Disease Manifesting as a Pancreatic Head Mass Diagnosed Nonoperatively.
    J Oncol Pract Volume: 13 Page(s): 61 - 62
    01/01/2017 Authors: Smith DJ; Sekhar A; Memis B; Adsay VN; Alese OB
  • Novel synthetic curcumin analogs as potent antiangiogenic agents in colorectal cancer.
    Mol Carcinog Volume: 56 Page(s): 288 - 299
    01/01/2017 Authors: Rajitha B; Nagaraju GP; Shaib WL; Alese OB; Snyder JP; Shoji M; Pattnaik S; Alam A; El-Rayes BF
  • Aquaporins: Their role in gastrointestinal malignancies.
    Cancer Lett Volume: 373 Page(s): 12 - 18
    04/01/2016 Authors: Nagaraju GP; Basha R; Rajitha B; Alese OB; Alam A; Pattnaik S; El-Rayes B
  • Contemporary Management of Borderline Resectable and Locally Advanced Unresectable Pancreatic Cancer.
    Oncologist Volume: 21 Page(s): 178 - 187
    02/01/2016 Authors: Shaib WL; Ip A; Cardona K; Alese OB; Maithel SK; Kooby D; Landry J; El-Rayes BF
  • MicroRNAs as biomarkers and prospective therapeutic targets in colon and pancreatic cancers.
    Tumour Biol Volume: 37 Page(s): 97 - 104
    01/01/2016 Authors: Nagaraju GP; Madanraj AS; Aliya S; Rajitha B; Alese OB; Kariali E; Alam A; El-Rayes BF
  • Therapy-related acute myeloid leukemia following radioactive iodine treatment for thyroid cancer.
    Cancer Causes Control Volume: 27 Page(s): 143 - 146
    01/01/2016 Authors: Oluwasanjo A; Pathak R; Ukaigwe A; Alese O
  • Analysis of liver-directed therapies in U.S. cancer patients.
    Curr Oncol Volume: 22 Page(s): e457 - e461
    12/01/2015 Authors: Alese OB; Kim S; Chen Z; Ramalingam SS; Owonikoko TK; El-Rayes BF
  • Rasburicase-induced methaemoglobinaemia and G6PD deficiency in an unusual suspect.
    Br J Haematol Volume: 170 Page(s): 595
    09/01/2015 Authors: Oluwasanjo A; Alese O; Swierczynski S; Forman D
  • Management and Outcomes of Hospitalized Patients With Primary Neuroendocrine Tumor and Non-Neuroendocrine Tumor Appendiceal Cancers in the United States.
    World J Oncol Volume: 6 Page(s): 349 - 354
    06/01/2015 Authors: Alese OB; Kim S; Chen Z; Shaib W; Staley CA; Ramalingam SS; Owonikoko TK; El-Rayes BF
  • Management patterns and predictors of mortality among US patients with cancer hospitalized for malignant bowel obstruction.
    Cancer Volume: 121 Page(s): 1772 - 1778
    06/01/2015 Authors: Alese OB; Kim S; Chen Z; Owonikoko TK; El-Rayes BF
  • Borderline resectable (BRPC) and locally advanced unresectable (LAPC) pancreas cancer treatment: A single Institution experience.
    Volume: 33
    05/20/2015 Authors: Shaib WL; Qu J; Zhang C; Ip A; Chen Z; El-Rayes BF; Alese O
  • Management and outcomes of hospitalized patients with primary neuroendocrine tumor (NET) and non-NET appendiceal cancers in the United States.
    Volume: 33
    05/20/2015 Authors: Alese OB; Kim S; Chen Z; Shaib WL; Owonikoko TK; El-Rayes BF
  • Pattern of liver-directed therapies and outcomes in cancer patients hospitalized in the United States
    Volume: 33
    05/20/2015 Authors: Alese OB; Kim S; Chen Z; Owonikoko TK; El-Rayes BF
  • Anaplastic lymphoma kinase (ALK) gene alteration in signet ring cell carcinoma of the gastrointestinal tract.
    Ther Adv Med Oncol Volume: 7 Page(s): 56 - 62
    03/01/2015 Authors: Alese OB; El-Rayes BF; Sica G; Zhang G; Alexis D; La Rosa FG; Varella-Garcia M; Chen Z; Rossi MR; Adsay NV
  • Role of adiponectin in obesity related gastrointestinal carcinogenesis.
    Cytokine Growth Factor Rev Volume: 26 Page(s): 83 - 93
    02/01/2015 Authors: Nagaraju GP; Aliya S; Alese OB
  • HSP90 inhibition downregulates thymidylate synthase and sensitizes colorectal cancer cell lines to the effect of 5FU-based chemotherapy.
    Oncotarget Volume: 5 Page(s): 9980 - 9991
    10/30/2014 Authors: Nagaraju GP; Alese OB; Landry J; Diaz R; El-Rayes BF
  • Mortality from malignant bowel obstruction in hospitalized US cancer patients
    Volume: 32
    05/20/2014 Authors: Alese OB; Kim S; Chen Z; Owonikoko TK; El-Rayes BF
  • Multiplatform assessment of anaplastic lymphoma kinase (ALK) gene rearrangement in signet ring cell carcinoma of the gastrointestinal tract
    Volume: 31
    05/20/2013 Authors: Alese OB; El-Rayes BF; Sica G; Zhang G; Rossi MR; Adsay V; Alexis D; La Rosa FG; Varella-Garcia M; Chen Z
  • Mucinous cystadenoma of the appendix: a case report.
    Afr Health Sci Volume: 10 Page(s): 99 - 100
    03/01/2010 Authors: Alese OB; Irabor DO
  • Adenomatous polyposis coli in an elderly female nigerian.
    Ghana Med J Volume: 43 Page(s): 139 - 141
    09/01/2009 Authors: Alese OB; Irabor DO
  • Pyoderma gangrenosum and ulcerative colitis in the tropics.
    Rev Soc Bras Med Trop Volume: 41 Page(s): 664 - 667
    01/01/2008 Authors: Alese OB; Irabor DO
  • Epidemiology of cancer in the middle age and elderly populations in a developing economy: Need for proper resource allocation and personnel training
    Volume: 25
    06/20/2007 Authors: Alese OB; Obamuyide HA
  • Epidemiology of cancer in the mid age and elderly populations in a developing economy; need for proper resource allocation and personnel training
    Volume: 16 Page(s): S60 - S60
    03/01/2007 Authors: Alese OB; Obamuyide HA; Faturoti OI
  • On-site physicians at a major sporting event in Nigeria.
    Prehosp Disaster Med Volume: 21 Page(s): 40 - 44
    01/01/2006 Authors: Olapade-Olaopa EO; Alonge TO; Amanor-Boadu SD; Sanusi AA; Alese OB; Omisanjo OO; Adeyinka AO; Sanya AO; Ogunbunmi PA; Adewole IF
  • Prevalence of skin diseases in Ibadan, Nigeria.
    Int J Dermatol Volume: 43 Page(s): 31 - 36
    01/01/2004 Authors: Ogunbiyi AO; Daramola OOM; Alese OO
Read more publications Fewer publications
Directory
  • Faculty Profiles
Emory University Homepage

Contact & Location

Emory University School of Medicine
100 Woodruff Circle
Atlanta, GA  30322 USA
  • Contact Us
  • Maps & Directions
  • Careers

Information For

  • Alumni
  • Faculty & Staff
  • Patients
  • Residents & Fellows
  • Students
Support the School of Medicine School of Medicine Intranet
facebook facebook twitter twitter linkedin linkedin instagram instagram youtube youtube
© 2025 Emory University
  • Privacy Policy
  • Emergency Information
  • EEO Employer-Disability/Veteran Statements